FISH VET GROUP LIMITED

What FISH VET GROUP LIMITED does

PHARMAQ AS, operating commercially under the brand Fish Vet Group in the United Kingdom, is a Norwegian animal-health company specializing in aquaculture, founded in 1986 and headquartered in Overhalla, Norway. It is a wholly-owned subsidiary of Zoetis, the world leader in animal health, having been acquired in 2020, and operates globally through seven regional subsidiaries in Chile, the United Kingdom, Vietnam, Turkey, Spain, Panama, and Hong Kong. The company employs approximately 300–420 people worldwide and delivered an estimated 2 billion fish vaccine doses in 2025, supported by 39 years of dedicated R&D.

The company operates a three-pillar product platform under the sub-brands PHARMAQ, Fishteq, and Analytiq. PHARMAQ develops and supplies vaccines and therapeutics for salmonids, tilapia, pangasius, sea bass, and cleaner fish. Fishteq manufactures vaccination equipment including Micro-Matic syringes and vaccination machines, and provides professional vaccination services. Analytiq offers advanced diagnostic services — Real-time RT-PCR, histopathology, SmoltVision, microbiology, NGS, and data analytics — along with consultancy and training, with results accessible through the iWISE Customer Health Portal.

The business model is B2B enterprise sales-led, with quote-based, non-publicly disclosed pricing targeting aquaculture operators globally. Primary customers are salmonid farmers, with secondary segments in warm-water species and equipment operators. Revenue is generated through one-time sales of vaccines and therapeutics, hardware sales of vaccination machinery, and professional diagnostic and vaccination services. Marketing and distribution rely on direct sales, regional subsidiaries, industry events, digital content, and the iWISE customer portal.

Name

FISH VET GROUP LIMITED

Legal name

PHARMAQ AS

Website

https://fishvetgroup.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

11–50 employees

Short description

PHARMAQ AS, operating as Fish Vet Group in the UK, is a Norwegian aquaculture health company and Zoetis subsidiary that develops vaccines, vaccination equipment, and diagnostic services for global salmonid, tilapia, pangasius, and sea bass farmers.

Ownership category

akta.pro rank

Product category

Aquaculture Health Products

NAICS

Aquaculture (1125), Veterinary Services (54194)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Aquaculture Health, Biosecurity & Veterinary Services (AFAEAAAK)

akta.pro secondary industries

Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK), Aquaculture & Fish Health Services (AFAEANAE)

Keywords

• Aquaculture vaccines
• Fish health products
• Vaccination equipment
• Fish diagnostics services
• Aquaculture therapeutics

Headquarters

HQ city

Overhalla

HQ country

Norway

HQ region

Europe

Offices9 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Vaccines and Therapeutics Products: Sale of fish health vaccines and therapeutic products to aquaculture companies globally
2. Vaccination Equipment: Sale and service of vaccination machinery including machines and syringes
3. Diagnostic Services: Laboratory diagnostic services including Real-time RT-PCR, histopathology, microbiology, NGS, and data analytics

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

FISH VET GROUP LIMITED operates the PHARMAQ aquaculture health business, developing, manufacturing, and selling fish vaccines and therapeutics for species including salmonids, tilapia, pangasius, sea bass, and cleaner fish. It also produces vaccination equipment (Micro-Matic syringes and vaccination machines), provides professional vaccination services, and runs a diagnostics laboratory offering Real-time RT-PCR, Histopathology, SmoltVision, Microbiology, NGS, data analytics, and consultancy to fish farmers globally.

Product overview

PHARMAQ operates as a multi-brand platform for aquaculture health solutions, comprising three main product lines: PHARMAQ (vaccines and therapeutics), FISHTEQ (vaccination equipment and services), and ANALYTIQ (diagnostics and data analytics). The company is the global leader in aquaculture vaccines, delivering approximately 2 billion fish vaccine doses annually, and offers a comprehensive portfolio spanning vaccine development, vaccination machinery, and advanced diagnostic services including Real-time RT-PCR, Histopathology, SmoltVision, Microbiology, NGS, and Data Analytics. PHARMAQ is a subsidiary of Zoetis, the world leader in animal health.

Differentiator

Problem solved

Functional benefit

Brands

• PHARMAQ: Vaccines and therapeutics for aquaculture - global leader in vaccine development and innovation
• Fishteq
• Analytiq

Products and services

• PHARMAQ Vaccines and Therapeutics

Quantifiable outcome

• 2 billion fish vaccine doses delivered in 2025
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• ZoetiscoreOthersPHARMAQ is part of Zoetis, the world leader in animal health. Zoetis is the parent company providing global scale and resources for the aquaculture health business unit.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Virbac: Independent global animal health company offering vaccines, diagnostics, and pharmaceuticals for both companion and production animals including aquaculture. Competes with PHARMAQ in select species and markets.
• Elanco Animal Health: Global animal health company with portfolio across companion and production animals, including aquaculture-relevant products. Larger incumbent with broader species coverage; competes with Zoetis/PHARMAQ across animal health broadly.
• MSD Animal Health: Division of Merck offering vaccines, parasiticides, and health management tools across multiple species including aquaculture. Shares the aquaculture vaccines market with PHARMAQ and competes on R&D breadth and global distribution.

Direct peers

• Hipra: Spanish animal health company with a dedicated aquaculture health business developing vaccines and therapeutics for farmed fish. Direct competitor to PHARMAQ in aquaculture vaccines, particularly in warm-water species and Mediterranean markets.
• Ceva Santé Animale: Global animal health company headquartered in France with aquaculture vaccines and therapeutics as a core focus. Direct competitor in fish vaccines and a comparable challenger in the aquaculture health segment.
• Benchmark Holdings: UK-based aquaculture biotechnology company providing salmon breeding, health, and nutrition solutions. Overlaps with PHARMAQ in aquaculture health services and genetics, though its primary focus is breeding and的营养 rather than vaccines.

Others

• Skretting: Global aquaculture feed producer owned by Nutreco. Adjacent rather than directly competing; its customer base overlaps with PHARMAQ's, enabling potential partnership and cross-selling opportunities in fish health.
• Cargill Aqua Nutrition: Aquaculture feed division of Cargill serving salmon, shrimp, and other farmed species. Adjacent rather than directly competing; serves the same aquaculture customers as PHARMAQ and is a potential channel partner for integrated health offerings.

Emerging players

• AquaBounty Technologies: Aquaculture biotech company focused on genetically engineered salmon for faster growth. Different product category (genetics vs. health) but operates in the same salmonid aquaculture ecosystem and shares the same customer base as PHARMAQ.

Regional players

• AquaGen: Norway-based aquaculture breeding company supplying salmon and trout eggs with health and genetic selection emphasis. Adjacent to PHARMAQ's salmonid health focus and based in the same core market, but sells breeding stock rather than health products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/fish-vet-group-limited

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FISH VET GROUP LIMITED